Director, Global Value, Access & Pricing, Solid Tumors & Pipeline

Scorpion Therapeutics; United States; On-site; USD 150,000 - 230,000; Full time

Job summary

Scorpion Therapeutics in the United States is seeking a Senior Manager to develop global market access strategies for solid tumor assets, aligning pricing, evidence generation, and payer engagement with clinical and commercial objectives.

You will lead pricing and access strategy development, identify evidentiary gaps affecting reimbursement, and collaborate with Clinical, Medical, HEOR, and regional teams to support pre-launch planning and regional market entry.

Qualifications

• BA/BS with 10+ years pharmaceutical experience.
• 5+ years in global/regional market access, oncology preferred.
• Deep understanding of pricing, reimbursement landscapes, and health economics.

Responsibilities

• Lead creation and implementation of pricing and access strategies.
• Identify evidentiary gaps impacting reimbursement.
• Collaborate with Clinical, Medical, HEOR, and Regional teams across functions.
• Support pre-launch access planning and monitor payer landscape.

Skills

Market access

Pricing strategy

HEOR

Payer engagement

Oncology

Education

BA/BS in life sciences or related field

Job description

Role:

Senior Manager responsible for developing global market access strategies for solid tumor pipeline assets (typically Phase II/III), ensuring alignment with clinical and commercial objectives.

Responsibilities:

lead creation and implementation of pricing and access strategies, identify evidentiary gaps impacting reimbursement, collaborate cross-functionally with Clinical, Medical, HEOR, and Regional teams, support pre-launch access planning, and monitor competitor and payer landscape.

Key duties include

shaping evidence generation plans, developing value propositions, and supporting regional adaptation for market entry.

Requirements:

BA/BS with 10+ years pharmaceutical experience, including at least 5 years in global/regional market access, oncology expertise preferred.

Deep understanding of global pricing, reimbursement landscapes, and health economics, with experience in pipeline/early development and JCA preparation advantageous.

HighValue:

Oncology (Solid Tumors), pipeline assets (Phase II/III), market access strategy development, payer engagement, health economics, and evidence generation.

WorkSetup:

East Coast (EST) preferred; travel requirements not specified.